CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.

[Revised] Resolutions for Convocation of General Meeting of Shareholders(ììì£¼ì£¼ì´í)

[Revised] Resolutions for Convocation of General Meeting of Shareholders

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CanariaBio (016790 KS)

[Revised] Resolutions for Convocation of General Meeting of Shareholders(ììì£¼ì£¼ì´í)

[Revised] Resolutions for Convocation of General Meeting of Shareholders

Loan(s)(Voluntary Disclosure)

Loan(s)

Change of Trading Suspension Period(ê°ì ê¸°ê° ë¶ì¬)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

[Revised] Resolutions for Convocation of General Meeting of Shareholders(ììì£¼ì£¼ì´í)

[Revised] Resolutions for Convocation of General Meeting of Shareholders

Loan(s)(Voluntary Disclosure)

Loan(s)

Change of Trading Suspension Period(ê°ì ê¸°ê° ë¶ì¬)

[Revised] Resolutions for Convocation of General Meeting of Shareholders(ììì£¼ì£¼ì´í)

Change of Trading Suspension Period(ê°ì ê¸°ê° ë¶ì¬)